zolmitriptan has been researched along with Acathisia, Drug-Induced in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Avital, A; Gross-Isseroff, R; Hermesh, H; Shiloh, R; Stryjer, R; Weizman, A | 1 |
| Gross-Isseroff, R; Hermesh, H; Magen, A; Shiloh, R; Weizman, A | 1 |
2 trial(s) available for zolmitriptan and Acathisia, Drug-Induced
| Article | Year |
|---|---|
Zolmitriptan compared to propranolol in the treatment of acute neuroleptic-induced akathisia: a comparative double-blind study.
Topics: Adrenergic beta-Antagonists; Adult; Akathisia, Drug-Induced; Anticonvulsants; Blood Pressure; Double-Blind Method; Epilepsy; Female; Humans; Inpatients; Male; Middle Aged; Oxazolidinones; Propranolol; Serotonin Receptor Agonists; Severity of Illness Index; Time Factors; Tryptamines | 2009 |
The 5-HT1D receptor agonist zolmitriptan for neuroleptic-induced akathisia: an open label preliminary study.
Topics: Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Female; Humans; Male; Middle Aged; Oxazolidinones; Psychiatric Status Rating Scales; Schizophrenia; Serotonin; Serotonin Receptor Agonists; Treatment Outcome; Tryptamines | 2005 |